Home
Live Updates
Survival Benefits with Keytruda and Padcev in Advanced Urothelial Cancer : comparemela.com
Survival Benefits with Keytruda and Padcev in Advanced Urothelial Cancer
Patients with previously untreated locally advanced or metastatic urothelial carcinoma experienced favorable progression-free survival, overall survival and objective response rates when treated with Padcev and Keytruda versus chemotherapy.
Related Keywords
United States ,
Netherlands ,
America ,
Padcev Keytruda ,
Michiels Van ,
Michiel Van Der Heijden Research Group ,
Netherlands Cancer Institute ,
Drug Administration ,
Cancers Symposium ,
Der Heijden ,
Michiel Van ,
Heijden Research Group ,
North America ,
Bladder Cancer ,
Immunotherapy ,
Genitourinary Cancers Symposium ,
comparemela.com © 2020. All Rights Reserved.